Surmodics Cash Conversion Cycle 2011-2026 | SRDX

Annual Cash Conversion Cycle Surmodics

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
169	179	158	129	114	78	54.8	48.4	63	76.5	57.9	72.4	127	117

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
179	48.4	103

Quarterly Cash Conversion Cycle Surmodics

2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
158	187	194	-	171	191	158	-	166	202	205	-	85.5	157	150	-	121	136	152	66.7	117	117	104	48.7	99.2	92.3	75.6	48.7	69.1	76.5	79.6	45.4	72.1	36.8	34.4	34.5	31.4	31.8	35.9	39.3	42.9	32.9	29.5	28.3	29.7	33.1	34.3	35.1	34.9	32.5	31.2	32.4	32.4	32.4	30.1	28.8	30.8	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
205	28.3	81.9

Cash Conversion Cycle of other stocks in the Diagnostics research industry

Issuer	Cash Conversion Cycle	Price	% 24h	Market Cap	Country
Akumin AKU	36.1	-	-17.87 %	$ 25.9 M	Canada
Co-Diagnostics CODX	-2.46 K	$ 1.63	-1.52 %	$ 2.17 M	USA
Centogene N.V. CNTG	50.2	-	-6.23 %	$ 30.6 M	Germany
Agilent Technologies A	111	$ 115.26	-0.31 %	$ 35 B	USA
Accelerate Diagnostics AXDX	364	-	-61.36 %	$ 2.46 M	USA
Chembio Diagnostics CEMI	111	-	0.22 %	$ 16.8 M	USA
Illumina ILMN	142	$ 126.83	-1.31 %	$ 20.2 B	USA
Aspira Women's Health AWH	1.01 K	-	-6.19 %	$ 10.5 M	USA
Biocept BIOC	78.1	-	-13.05 %	$ 7.29 M	USA
Castle Biosciences CSTL	45.9	$ 24.61	-1.48 %	$ 684 M	USA
Lantheus Holdings LNTH	97.3	$ 82.83	-1.52 %	$ 5.59 B	USA
National Research Corporation NRC	29.4	$ 16.85	-1.52 %	$ 377 M	USA
Enzo Biochem ENZ	154	-	-8.98 %	$ 14.8 K	USA
CareDx, Inc CDNA	51.5	$ 22.39	2.47 %	$ 1.19 B	USA
Koninklijke Philips N.V. PHG	89	$ 27.06	-1.74 %	$ 20 B	Niderland
Precipio PRPO	19.9	$ 31.9	2.9 %	$ 51.2 M	USA
Personalis PSNL	-11.5	$ 5.43	-8.89 %	$ 322 M	USA
DermTech DMTK	66.7	-	-11.32 %	$ 2.94 M	USA
Senseonics Holdings SENS	36.1	$ 7.15	-1.72 %	$ 298 M	USA
Exact Sciences Corporation EXAS	42.5	-	-	$ 19.8 B	USA
Fulgent Genetics FLGT	42.4	$ 15.19	-2.63 %	$ 459 M	USA
HTG Molecular Diagnostics HTGM	104	-	-20.0 %	$ 1.06 M	USA
Global Cord Blood Corporation CO	184	-	-	$ 399 M	China
Genetic Technologies Limited GENE	11 K	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	142	-	0.12 %	$ 80.1 M	China
Thermo Fisher Scientific TMO	70	$ 470.48	0.52 %	$ 177 B	USA
Charles River Laboratories International CRL	65	$ 166.04	-3.03 %	$ 8.23 B	USA
PRA Health Sciences, Inc. PRAH	1.21 K	-	-	$ 10.7 B	USA
Trinity Biotech plc TRIB	136	$ 0.63	-2.99 %	$ 61.9 M	Irlanda
Guardant Health GH	79.6	$ 83.59	-5.55 %	$ 10.5 B	USA
Twist Bioscience Corporation TWST	83.6	$ 59.97	-1.7 %	$ 3.59 B	USA
Heska Corporation HSKA	138	-	-	$ 1.31 B	USA
Interpace Biosciences IDXG	62.9	$ 1.93	-	$ 8.54 M	USA
Medpace Holdings MEDP	50.4	$ 415.77	-1.33 %	$ 12 B	USA
QIAGEN N.V. QGEN	122	-	-	$ 10.6 B	Niderland
Motus GI Holdings MOTS	3.45 K	-	-34.28 %	$ 263 K	Israel
Biomerica BMRA	172	$ 2.19	0.23 %	$ 5.03 M	USA
ICON Public Limited Company ICLR	62	$ 101.26	-1.89 %	$ 8.35 B	Irlanda
Laboratory Corporation of America Holdings LH	40.3	$ 260.26	-1.2 %	$ 21.7 B	USA
Neogen Corporation NEOG	150	$ 9.22	-2.49 %	$ 2 B	USA
NeoGenomics NEO	82.4	$ 8.96	4.01 %	$ 1.15 B	USA
Myriad Genetics MYGN	49.3	$ 4.88	1.04 %	$ 452 M	USA
Natera NTRA	81.5	$ 202.48	-0.93 %	$ 19.9 B	USA
Quest Diagnostics Incorporated DGX	39.5	$ 195.25	-0.7 %	$ 21.7 B	USA
Invitae Corporation NVTA	299	-	-	$ 21.2 M	USA
OpGen OPGN	4.66	-	-16.95 %	$ 1.54 M	USA